Chemotherapy-induced Febrile Neutropenia (FN)
Also known as: Chemotherapy-Induced Febrile Neutropenia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15001 | Eflapegrastim | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15001 | Eflapegrastim | Granulocyte colony-stimulating factor receptor | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00099 | Filgrastim | 3 | Completed | 1 |
| DB00019 | Pegfilgrastim | 3 | Completed | 1 |
| DB00099 | Filgrastim | 4 | Unknown Status | 1 |
| DB00099 | Filgrastim | Not Available | Completed | 1 |